Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Plinabulin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BeyondSpring Presents Phase 2 Efficacy of Pembrolizumab Combo
    BeyondSpring Presents Phase 2 Efficacy of Pembrolizumab Combo

    11 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/11/2978241/0/en/BeyondSpring-Presents-Updated-Efficacy-Results-from-a-Phase-2-IIT-Study-of-Triple-IO-Combo-of-Pembrolizumab-plus-Plinabulin-Docetaxel-in-Metastatic-NSCLC-after-Progressing-on-Prior.html

    GLOBENEWSWIRE
    11 Nov 2024
    Share Share
    BeyondSpring Presents DUBLIN-3 Data At ESMO 2024
    BeyondSpring Presents DUBLIN-3 Data At ESMO 2024

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2946478/0/en/BeyondSpring-Presents-Final-Data-Analysis-of-DUBLIN-3-Phase-3-Study-in-2L-3L-EGFR-Wild-type-NSCLC-at-ESMO-Congress-2024.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    BeyondSpring Presents Plinabulin Phase 3 Data At ISLAC 2024
    BeyondSpring Presents Plinabulin Phase 3 Data At ISLAC 2024

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943512/0/en/BeyondSpring-Delivers-Oral-Presentation-at-ISLAC-2024-World-Conference-on-Lung-Cancer-of-its-Lead-Anti-Cancer-Asset-Plinabulin-Showcasing-Positive-Final-Phase-3-Data-in-2L-3L-NSCLC.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    BeyondSpring Presents Plinabulin Data at Lung Cancer Conference and ESMO 2024
    BeyondSpring Presents Plinabulin Data at Lung Cancer Conference and ESMO 2024

    03 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/03/2939501/0/en/BeyondSpring-Announces-Oral-Presentation-at-the-2024-World-Conference-on-Lung-Cancer-and-Two-Poster-Presentations-During-ESMO-Congress-2024-Showcasing-its-Lead-Anti-Cancer-Asset-Pl.html

    GLOBENEWSWIRE
    03 Sep 2024
    Share Share
    BeyondSpring Highlights Plinabulin Strategy, SEED Updates At R&D Day
    BeyondSpring Highlights Plinabulin Strategy, SEED Updates At R&D Day

    16 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/16/2883333/0/en/BeyondSpring-R-D-Day-Highlights-New-Plinabulin-Development-Strategy-for-Cancer-and-Updates-for-SEED-Therapeutics.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share
    BeyondSpring To Host R&D Day On Plinabulin, SEED Therapeutics
    BeyondSpring To Host R&D Day On Plinabulin, SEED Therapeutics

    03 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/03/2875017/0/en/BeyondSpring-To-Host-Virtual-R-D-Day-to-Discuss-New-Plinabulin-Development-Strategy-for-Cancer-and-Updates-for-SEED-Therapeutics.html

    GLOBENEWSWIRE
    03 May 2024
    Share Share